No disclosed counterparties: VLTO, XYL.
| Stage | VLTO | % of rev | XYL | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $1.5B | 100.00% | $2.2B | 100.00% | XYL ×1.46 |
| Gross profit | $908M | 60.17% | $907M | 41.21% | VLTO +19.0pp |
| Operating income | $298M | 19.75% | $385M | 17.49% | VLTO +2.3pp |
| Pre-tax income | $273M | 18.09% | $365M | 16.58% | VLTO +1.5pp |
| Net income | $253M | 16.77% | $288M | 13.08% | VLTO +3.7pp |
| Stage | VLTO | XYL | Gap · A − B |
|---|---|---|---|
| Revenue | $1.5B100.00% | $2.2B100.00% | XYL ×1.46 |
| Gross profit | 60.17%$908M | 41.21%$907M | VLTO +19.0pp |
| Operating income | 19.75%$298M | 17.49%$385M | VLTO +2.3pp |
| Pre-tax income | 18.09%$273M | 16.58%$365M | VLTO +1.5pp |
| Net income |
| 16.77%$253M |
| 13.08%$288M |
| VLTO +3.7pp |